Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Stefan Reers
Incidence of Left Atrial Abnormalities Under Treatment With Dabigatran, Rivaroxaban, and Vitamin K Antagonists
European Journal of Medical Research
Medicine
Related publications
Effectiveness and Safety of 110 or 150 Mg Dabigatran Versus Vitamin K Antagonists in Non-Valvular Atrial Fibrillation.
British Journal of Clinical Pharmacology
Pharmacology
Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Association of Vitamin D Deficiency With Electrocardiographic Markers of Left Atrial Abnormalities
Annals of Noninvasive Electrocardiology
Medicine
Cardiovascular Medicine
Physiology
Cardiology
Pcv79 - Real-World Cost-Effectiveness of Rivaroxaban Compared With Vitamin K Antagonists in the Context of Stroke Prevention in Atrial Fibrillation in France
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Dabigatran Compared With Rivaroxaban vs Warfarin
JAMA Internal Medicine
Internal Medicine
Patients’ Knowledge and Perspectives on Vitamin K Antagonists for Stroke Prevention in Atrial Fibrillation: Implications for Treatment Quality
Anatolian journal of cardiology
Cardiovascular Medicine
Cardiology
Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Safety and Efficacy of Triple Antithrombotic Therapy With Dabigatran Versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
